Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director departure
|
|
Hoth Therapeutics, Inc. (HOTH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/08/2023 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 4.2% stake in Hoth Therapeutics, Inc. |
| 02/23/2022 |
SC 13G/A
| Iroquois Capital Management, LLC reports a 5% stake in Hoth Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 5.6% stake in Hoth Therapeutics, Inc. |
| 02/09/2022 |
SC 13G/A
| Lind Global Macro Fund LP reports a 3.2% stake in Hoth Therapeutics, Inc. |
| 02/03/2022 |
SC 13G/A
| Ionic Ventures, LLC reports a 1.7% stake in Hoth Therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| EITNER MATTHEW D. has filed a Schedule 13D for HOTH THERAPEUTICS, INC. |
|
|